The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04
Open accessAbstract
Purpose: To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin (DP) after concurrent chemoradiotherapy (CCRT) with the same agents in locally advanced non–small-cell lung cancer (LA-NSCLC). Patient and Methods: Patients were randomly assigned to either CCRT alone (observation arm) or CCRT followed by CC (consolidation arm). CCRT with docetaxel (20 mg/m 2) and cisplatin (20 mg/m 2) was administered every week for 6 weeks with a total dose of 66 Gy of thoracic radiotherapy in 33 fractions. In the consolidation arm, patients were further treated with three cycles of DP (35 mg/m 2 each on days 1 and 8, every 3 weeks). The primary end point was 40% improvement in progression-free survival (PFS) compared with observation. Results: From October 2005 to April 2011, 437 patients were randomly assigned. Seventeen patients did not start CCRT as a result of consent withdrawal or ineligibility reasons after random assignment, leaving 420 patients for this analysis (n = 211 for observation; n = 209 for consolidation). Patient characteristics were similar in both arms. In the consolidation arm, 143 patients (68%) received CC, of whom 88 (62%) completed three planned cycles. The median PFS was 8.1 months in the observation arm and 9.1 months in the consolidation arm (hazard ratio, 0.91; 95% CI, 0.73 to 1.12; P = .36). Median overall survival times were 20.6 and 21.8 months in the observation and consolidation arms, respectively (HR, 0.91; 95% CI, 0.72 to 1.25; P = .44). Conclusion: CC with DP after CCRT with weekly DP in LA-NSCLC failed to further prolong PFS. CCRT alone should remain the standard of care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Furuse, K., Fukuoka, M., Kawahara, M., Nishikawa, H., Takada, Y., Kudoh, S., Katagami, N., & Ariyoshi, Y. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2692 · Cited by 1,495
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
Schaake-Koning, C., van den Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B., Nijs, A., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260805 · Cited by 1,277
Curran, W. J., Paulus, R., Langer, C. J., Komaki, R., Lee, J. S., Hauser, S., Movsas, B., Wasserman, T., Rosenthal, S. A., Gore, E., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr325 · Cited by 1,233
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
Jung, K.-W., Won, Y.-J., Kong, H.-J., Oh, C.-M., Cho, H., Lee, D. H., & Lee, K. H. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2015.060 · Cited by 1,160
Self-citationDillman, R. O., Seagren, S. L., Propert, K. J., Guerra, J., Eaton, W. L., Perry, M. C., Carey, R. W., Frei, E. F., & Green, M. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231403 · Cited by 1,153
Lord, R. V., Brabender, J., Gandara, D. R., Alberola, V., Camps, C., Dómine, M., Cardenal, F., Sánchez, J. M., Gumerlock, P. H., Tarón, M., et al. (2002) · PubMed · Cited by 668
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
Sause, W., Kolesar, P., Taylor, S., Johnson, D., Livingston, R., Komaki, R., Emami, B., Curran, W., Byhardt, R., Dar, A. R., et al. (2000) · Chest · doi:10.1378/chest.117.2.358 · Cited by 627
Butts, C., Socinski, M. A., Mitchell, P. L., Thatcher, N., Havel, L., Krzakowski, M., Nawrocki, S., Ciuleanu, T.-E., Bosquée, L., Trigo, J. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70510-2 · Cited by 538
Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
Jung, K.-W., Won, Y.-J., Kong, H.-J., Oh, C.-M., Seo, H. G., & Lee, J.-S. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.1.1 · Cited by 432
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
Friboulet, L., Olaussen, K. A., Pignon, J.-P., Shepherd, F. A., Tsao, M.-S., Graziano, S., Kratzke, R., Douillard, J.-Y., Seymour, L., Pirker, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214271 · Cited by 371
Gandara, D. R., Chansky, K., Albain, K. S., Leigh, B. R., Gaspar, L. E., Lara, P. N., Burris, H., Gumerlock, P., Kuebler, J. P., Bearden, J. D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.197 · Cited by 366
Kerr, K. M., Bubendorf, L., Edelman, M. J., Marchetti, A., Mok, T., Novello, S., O'Byrne, K., Stahel, R., Peters, S., Felip, E., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu145 · Cited by 298
Aupérin, A., Le Péchoux, C., Pignon, J. P., Koning, C., Jeremic, B., Clamon, G., Einhorn, L., Ball, D., Trovo, M. G., Groen, H. J. M., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj117 · Cited by 293
Schuette, W., Nagel, S., Blankenburg, T., Lautenschlaeger, C., Hans, K., Schmidt, E.-W., Dittrich, I., Schweisfurth, H., von Weikersthal, L. F., Raghavachar, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3739 · Cited by 179
on behalf of the DISTAL (Docetaxel In Second-line Treatment of Advanced Lung cancer) Investigators, Gridelli, C., Gallo, C., Di Maio, M., Barletta, E., Illiano, A., Maione, P., Salvagni, S., Piantedosi, F. V., Palazzolo, G., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602241 · Cited by 162
Bradley, J. D., Paulus, R., Komaki, R. U., Masters, G. A., Forster, K. M., Schild, S. E., Bogart, J. A., Garces, Y. I., Narayan, S., Kavadi, V. S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.7501 · Cited by 150
Bepler, G., Williams, C. C., Schell, M. J., Chen, W., Zheng, Z., Simon, G. R., Gadgeel, S. M., Zhao, X., Schreiber, F. J., Brahmer, J. R., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9783 · Cited by 149
Camps, C., Massutí, B., Jiménez, A., Maestu, I., Gómez, R. G., Isla, D., González, J., Almenar, D., Blasco, A., Rosell, R., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj115 · Cited by 131
Tsujino, K., Kurata, T., Yamamoto, S., Kawaguchi, T., Kubo, A., Isa, S., Hasegawa, Y., Ou, S. I., Takada, M., & Ando, M. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182988348 · Cited by 115
Dumontet, C., Isaac, S., Souquet, P.-J., Bejui-Thivolet, F., Pachéco, Y., Peloux, N., Frankfurter, A. J., Ludueña, R. F., & Pérol, M. (2005) · PubMed · Cited by 101
Azuma, K., Komohara, Y., Sasada, T., Terazaki, Y., Ikeda, J., Hoshino, T., Itoh, K., Yamada, A., & Aizawa, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00557.x · Cited by 98
Davidoff, A. J., Gardner, J. F., Seal, B. S., & Edelman, M. J. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820eed00 · Cited by 75
on behalf of Bio-FAST trial group, Tiseo, M., Bordi, P., Bortesi, B., Boni, L., Boni, C., Baldini, E., Grossi, F., Recchia, F., Zanelli, F., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.127 · Cited by 73
Socinski, M. A., Zhang, C., Herndon, J. E., Dillman, R. O., Clamon, G. H., Vokes, E. E., Akerley, W., Crawford, J., Perry, M. C., Seagren, S. L., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh282 · Cited by 66
Bria, E., Cuppone, F., Ciccarese, M., Nisticò, C., Facciolo, F., Milella, M., Izzo, F., Terzoli, E., Cognetti, F., & Giannarelli, D. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.07.003 · Cited by 64
The Role of Consolidation Treatment in Locally Advanced Unresectable NSCLC
Fakhrejahani, F., Sadraei, N. H., & Mekhail, T. M. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0330-8 · Cited by 3
Cited by
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709937 · Cited by 4,593
Self-citationOverall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798
Self-citationPostmus, P. E., Kerr, K. M., Oudkerk, M., Senan, S., Waller, D. A., Vansteenkiste, J., Escriu, C., & Peters, S. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx222 · Cited by 2,302
Spigel, D. R., Faivre-Finn, C., Gray, J. E., Vicente, D., Planchard, D., Paz-Ares, L., Vansteenkiste, J. F., Garassino, M. C., Hui, R., Quantin, X., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01308 · Cited by 1,445
Self-citationChaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,072
Metadata
- Authors
- Ahn, J. S., Ahn, Y. C., Kim, J.-H., Lee, C. G., Cho, E. K., Lee, K. C., Chen, M., Kim, D.-W., Kim, H.-K., Min, Y. J., Kang, J.-H., Choi, J.-H., Kim, S.-W., Zhu, G., Wu, Y.-L., Kim, S. R., Lee, K. H., Song, H. S., Choi, Y.-L., Sun, J.-M., Jung, S.-H., Ahn, M.-J., & Park, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-08-20
- Volume
- 33
- Issue
- 24
- Pages
- 2660-2666
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2149089484
- Cited by
- 261
- References
- 29
- FWCI
- 17.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.